{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:11:29Z","timestamp":1787598689050,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.urology.2025.01.061","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T16:56:20Z","timestamp":1738860980000},"page":"104-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Prognostic Value of Cribriform and Intraductal Carcinoma in Grade Group 2 Prostate Cancer With and Without Synchronous Nodal Metastases at Radical Prostatectomy: Results From a Case-control Matched, Multicenter Study"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2102-7897","authenticated-orcid":false,"given":"Hilda A.","family":"de Barros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Downes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Droghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise M.","family":"Bekers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Giunchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Brunocilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Schiavina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodorus H.","family":"van der Kwast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim J.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk G.","family":"van der Poel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2025.01.061_bib1","first-page":"1459","article-title":"Extended pelvic lymph node dissection in prostate cancer: a\u00a020-year audit in a single center","volume":"24","author":"Abdollah","year":"2013","journal-title":"Ann\u00a0Oncol"},{"key":"10.1016\/j.urology.2025.01.061_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142020 Update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2025.01.061_bib3","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2011.10.044","article-title":"Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores","volume":"61","author":"Briganti","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2025.01.061_bib4","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/bju.13623","article-title":"Metastatic potential to regional lymph nodes with Gleason score \u22647, including tertiary pattern 5, at radical prostatectomy","volume":"119","author":"Diolombi","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2025.01.061_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/pros.24279","article-title":"Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease","volume":"82","author":"Ma","year":"2022","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2025.01.061_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41379-018-0157-9","article-title":"Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis","volume":"32","author":"Hollemans","year":"2019","journal-title":"Modern Pathol"},{"key":"10.1016\/j.urology.2025.01.061_bib7","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/pros.23316","article-title":"Population-based validation of the 2014 ISUP Gleason Grade Groups in Patients treated with radical prostatectomy, brachytherapy, external beam radiation, or no local treatment","volume":"77","author":"Pompe","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2025.01.061_bib8","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/modpathol.2017.29","article-title":"Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer","volume":"30","author":"Kweldam","year":"2017","journal-title":"Modern Pathol"},{"key":"10.1016\/j.urology.2025.01.061_bib9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ejca.2020.09.016","article-title":"Cribriform architecture prostatic adenocarcinoma in needle biopsies is a strong independent predictor for lymph node metastases in radical prostatectomy","volume":"148","author":"Downes","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urology.2025.01.061_bib10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/his.14064","article-title":"Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy","volume":"76","author":"Hollemans","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.urology.2025.01.061_bib11","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.ejca.2014.03.009","article-title":"Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort","volume":"50","author":"Trudel","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urology.2025.01.061_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.21037\/tau.2017.12.33","article-title":"On cribriform prostate cancer","volume":"7","author":"Kweldam","year":"2018","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.urology.2025.01.061_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/modpathol.2014.116","article-title":"Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer","volume":"28","author":"Kweldam","year":"2015","journal-title":"Modern Pathol"},{"key":"10.1016\/j.urology.2025.01.061_bib14","unstructured":"G. JLH van Leenders, T.H. van der Kwast, D.J. Grignon, et al. The 2019 International Society of Urological Pathology ((ISUP)) Consensus Conference on Grading of Prostatic Carcinoma. 2020.\u3008www.ajsp.com\u3009."},{"key":"10.1016\/j.urology.2025.01.061_bib15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urology.2025.01.061_bib16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.eururo.2014.07.014","article-title":"Optimisation of fluorescence guidance during robot-assisted laparoscopic sentinel node biopsy for prostate cancer","volume":"66","author":"Kleinjan","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2025.01.061_bib17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/his.13938","article-title":"Gleason grade patterns in nodal metastasis and corresponding prostatectomy specimens: impact on patient outcome","volume":"75","author":"Downes","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.urology.2025.01.061_bib18","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/his.14590","article-title":"Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients","volume":"80","author":"Seyrek","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.urology.2025.01.061_bib19","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/his.15102","article-title":"Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer","volume":"84","author":"Greenland","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.urology.2025.01.061_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41379-018-0157-9","article-title":"Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis","volume":"32","author":"Hollemans","year":"2019","journal-title":"Modern Pathol"},{"key":"10.1016\/j.urology.2025.01.061_bib21","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/modpathol.2016.49","article-title":"Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy","volume":"29","author":"Kweldam","year":"2016","journal-title":"Modern Pathol"},{"key":"10.1016\/j.urology.2025.01.061_bib22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/pros.24279","article-title":"Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease","volume":"82","author":"Ma","year":"2022","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2025.01.061_bib23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/his.13893","article-title":"Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens","volume":"75","author":"Hollemans","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.urology.2025.01.061_bib24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/his.13747","article-title":"Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data set","volume":"74","author":"Masoomian","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.urology.2025.01.061_bib25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.euf.2023.08.010","article-title":"Limitations of prostate biopsy in detection of cribriform and intraductal prostate cancer","volume":"10","author":"Bernardino","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urology.2025.01.061_bib26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.urology.2022.04.043","article-title":"Predictive value of cribriform and intraductal carcinoma for the nomogram-based selection of prostate cancer patients for pelvic lymph node dissection","volume":"168","author":"de Barros","year":"2022","journal-title":"Urology"},{"key":"10.1016\/j.urology.2025.01.061_bib27","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.urology.2010.08.031","article-title":"Interobserver variability in histologic evaluation of radical prostatectomy between central and local pathologists: findings of TAX 3501 multinational clinical trial","volume":"77","author":"Netto","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urology.2025.01.061_bib28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.euf.2017.12.009","article-title":"The Impact of lymph node metastases burden at radical prostatectomy","volume":"5","author":"Preisser","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urology.2025.01.061_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fsurg.2016.00065","article-title":"Impact of lymph node burden on survival of high-risk prostate cancer patients following radical prostatectomy and pelvic lymph node dissection","volume":"3","author":"Moris","year":"2016","journal-title":"Front Surg"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429525001098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429525001098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T08:18:12Z","timestamp":1746519492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429525001098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":29,"alternative-id":["S0090429525001098"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2025.01.061","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Value of Cribriform and Intraductal Carcinoma in Grade Group 2 Prostate Cancer With and Without Synchronous Nodal Metastases at Radical Prostatectomy: Results From a Case-control Matched, Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2025.01.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}